Illuminated targets

Nature

Volumn 511, Issue 7508, 2014, Pages

  Cully, Megan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; PENTETRAZOLE; VALPROIC ACID;

BRAIN; DISEASE CONTROL; DRUG; IMMUNE RESPONSE; MOLECULAR ANALYSIS; NEUROLOGY;

ARTICLE; CONVULSION; DRUG DESIGN; DRUG RESEARCH; DRUG TARGETING; EPILEPSY; FISH; GENE MUTATION; MOLECULAR MEDICINE; NONHUMAN; PRIORITY JOURNAL; SEVERE MYOCLONIC EPILEPSY IN INFANCY; ANIMAL; CLINICAL TRIAL (TOPIC); DISEASE MODEL; DRUG DEVELOPMENT; HISTORY; HUMAN;

ANIMALS; ANTICONVULSANTS; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; DRUG DISCOVERY; EPILEPSY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS;

EID: 84904212837     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/511S12a     Document Type: Article

References (8)

1. Meunier, H. et al. Therapie 18, 435 (1963).
2. Chiron, C. & Olivier, O. Epilepsia 52, Supp. S2, 72-75 (2011).
3. Baraban, S. C., Dinday, M. T. & Hortopan, G. A. Nature Commun. 4, 2410 (2013).
4. Davies, A. et al. Trends Pharmacol. Sci. 28, 220-228 (2007).
5. Rogawski, M. Epilepsy Curr. 11, 56-63 (2011).
6. Lynch, B. A. et al. Proc. Natl Acad. Sci. USA 101, 9861-9866 (2004).
7. Mula, M. Expert Rev. Neurother. 14, 361-365 (2014).
8. Van Paesschen, W. V. et al. Epilespsia 54, 89-97 (2013).